drugset / Trial / NCT00553059
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Phase 3
Completed
62 enrolled
M.D. Anderson Cancer Center
National Cancer Institute (NCI) · collabSolvay Pharmaceuticals · collab
RandomizedSingle-groupTriple-blindSupportive care
Summary
The goal of this clinical research study is to learn if adding dronabinol in combination with the standard of care (dexamethasone and palonosetron) can better help to control nausea and vomiting in patients receiving chemotherapy. The safety of the drug combinations will also be studied.
Timeline
- Start
- 2008-05
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 5 mg | Oral |
| Background | Dexamethasone | Small molecule | 10 mg | Intravenous |
| Background | Palonosetron | Other / unclassified | 0.25 mg | Intravenous |